Immutep (IMMP) Interest Coverage Ratio (2015 - 2024)
Immutep's (IMMP) quarterly Interest Coverage Ratio came in at 143.84 in Q2 2016, down 460968266.54% YoY from N/an in Q3 2015, and down 460968266.54% on a QoQ basis from 0.0 in Q2 2015.
Immutep (IMMP) Interest Coverage Ratio (2015 - 2024) Analysis & Trends
Immutep (IMMP) has 2 years of Interest Coverage Ratio data on file, last reported at 143.84 in Q2 2016.
- Quarterly Interest Coverage Ratio fell 460968266.54% year-over-year to 143.84 in Q2 2016, while the trailing twelve-month figure through Jun 2017 was 739.94 (down 981035.7% YoY) and the FY2025 annual result came in at 1655.89, down 8.81% from the prior year.
- Interest Coverage Ratio eased to 143.84 in Q2 2016, from 0.0 in the prior quarter.
- In the past five years, Interest Coverage Ratio ranged from a high of 0.0 in Q2 2015 to a low of 143.84 in Q2 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - | 1.42 |
| 10 | Immutep | 56.94 Mn | -8.15 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 0.00 |
| Jun 30, 2024 | 205.55 |
| Dec 31, 2023 | 179.55 |
| Dec 31, 2022 | 187.74 |
| Dec 31, 2021 | 172.97 |
| Dec 31, 2019 | 113.08 |
| Jun 30, 2016 | -143.84 |
| Jun 30, 2015 | 0.00 |